MarketInOut Stock Screener Log In | Sign Up

SCHOTT Pharma AG & Co KGaA

XETRA • Healthcare • Medical Instruments & Supplies • Quote as of 10/30/2026
SCHOTT Pharma AG & Co KGaA stock price and volume chart

Company Profile

IndustryMedical Instruments & Supplies
SectorHealthcare
ExchangeXETRA
Market Capitalization3,810.55 mln
Float27.23 mln
Earnings Date12/10/2026

EPS

0.89
Moderate

P / E

28.09
Elevated

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.51
Likely reliable

1-Year Forecast

25.08
Fairly priced

Relative Strength

74 / 100
Outperforming

Business Description

SCHOTT Pharma AG & Co. KGaA is a Germany-based company that makes and sells packaging and delivery products for injectable medications, serving pharmaceutical, biotech, and life science companies around the world. Its product range includes glass and polymer syringes, vials, cartridges, and ampoules, along with supporting services such as analytics, regulatory guidance, and fill-and-finish solutions. Founded in 1884 and headquartered in Mainz, the company operates as a subsidiary of Schott Glaswerke Beteiligungs- und Export GmbH.

Key Fundamentals

EPS0.89
P/E28.09
ROE13.02
RPS6.73
ROIC9.73
ROA7.43
Interest Cover9.09
EBITDA, mln264
EV / EBITDA14.46
EV / EBIT21.63
Revenue, mln1,017
EV / Revenue3.75

Quote Details

Last 25.00
Change -0.3 (-1.19%)
Open 25.25
Volume 49,801
Turnover 1,245,025
Average Volume 59,735

Financial Ratios

Pre-Tax Profit Margin16
Current Ratio1.61
Price / Book3.86
Price / Tangible Book3.98
Price / Free Cash Flow69.48
Debt / Equity0.08
Price / Sales3.77
PEG Ratio1.62

Financial Strength

Altman Z-Score4.45
Piotroski F-Score 6 / 9
Beneish M-Score-2.51
Price to Lynch Fair Value1.51
Price to Graham Number2.23
1-Year Target Price25.08

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.72% 11 / 100   
1 Month 2.67% 64 / 100   
2 Months 15.74% 93 / 100   
6 Months 60.26% 99 / 100   
1 Year 30.34% 87 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog